NO20022103D0 - Ny kombinasjon innbefattende en beta 2 (<beta>)2 andrenore- septoragonist og leukotrienreseptorantagonist - Google Patents

Ny kombinasjon innbefattende en beta 2 (<beta>)2 andrenore- septoragonist og leukotrienreseptorantagonist

Info

Publication number
NO20022103D0
NO20022103D0 NO20022103A NO20022103A NO20022103D0 NO 20022103 D0 NO20022103 D0 NO 20022103D0 NO 20022103 A NO20022103 A NO 20022103A NO 20022103 A NO20022103 A NO 20022103A NO 20022103 D0 NO20022103 D0 NO 20022103D0
Authority
NO
Norway
Prior art keywords
beta
andrenoreceptor
agonist
receptor antagonist
combination including
Prior art date
Application number
NO20022103A
Other languages
English (en)
Norwegian (no)
Other versions
NO20022103L (no
Inventor
Jan Trofast
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of NO20022103L publication Critical patent/NO20022103L/no
Publication of NO20022103D0 publication Critical patent/NO20022103D0/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Otolaryngology (AREA)
  • Pain & Pain Management (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
NO20022103A 1999-11-03 2002-05-02 Ny kombinasjon innbefattende en beta 2 (<beta>)2 andrenore- septoragonist og leukotrienreseptorantagonist NO20022103D0 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9903995A SE9903995D0 (sv) 1999-11-03 1999-11-03 New combination
PCT/SE2000/002115 WO2001032163A1 (en) 1999-11-03 2000-10-27 NEW COMBINATION COMPRISING A BETA 2 (β)2 ADRENO RECEPTOR AGONIST AND A LENKOTRIENE RECEPTOR ANTAGONIST

Publications (2)

Publication Number Publication Date
NO20022103L NO20022103L (no) 2002-05-02
NO20022103D0 true NO20022103D0 (no) 2002-05-02

Family

ID=20417605

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20022103A NO20022103D0 (no) 1999-11-03 2002-05-02 Ny kombinasjon innbefattende en beta 2 (<beta>)2 andrenore- septoragonist og leukotrienreseptorantagonist

Country Status (13)

Country Link
EP (1) EP1242065A1 (xx)
JP (1) JP2003513037A (xx)
KR (1) KR20020050254A (xx)
CN (1) CN1387431A (xx)
AU (2) AU1652601A (xx)
BR (1) BR0015172A (xx)
CA (1) CA2388657A1 (xx)
IL (1) IL149365A0 (xx)
MX (1) MXPA02004334A (xx)
NO (1) NO20022103D0 (xx)
SE (1) SE9903995D0 (xx)
WO (2) WO2001032166A1 (xx)
ZA (1) ZA200203178B (xx)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030055026A1 (en) 2001-04-17 2003-03-20 Dey L.P. Formoterol/steroid bronchodilating compositions and methods of use thereof
US6667344B2 (en) 2001-04-17 2003-12-23 Dey, L.P. Bronchodilating compositions and methods
PE20050130A1 (es) * 2002-08-09 2005-03-29 Novartis Ag Compuestos organicos
GB0312148D0 (en) * 2003-05-28 2003-07-02 Aventis Pharma Ltd Stabilized pharmaceutical products
GB0315889D0 (en) 2003-07-08 2003-08-13 Aventis Pharma Ltd Stable pharmaceutical products
WO2005097095A1 (en) * 2004-04-05 2005-10-20 Sepracor Inc. (r,r)-formoterol in combination with other pharmacological agents
ES2245612B1 (es) * 2004-06-29 2007-08-16 Universidad De Barcelona Nuevo uso terapeutico del formoterol.
JP4991693B2 (ja) * 2005-03-16 2012-08-01 メダ ファーマ ゲゼルシャフト ミット ベシュレンクテル ハフツング ウント コンパニー コマンディトゲゼルシャフト 呼吸器疾患の治療のための抗コリン作用薬及びロイコトリエン受容体アンタゴニストの組み合わせ剤
CN103562185A (zh) 2011-06-06 2014-02-05 奇斯药制品公司 作为磷酸二酯酶抑制剂的1-苯基-2-吡啶基烷基醇的衍生物
KR102192739B1 (ko) * 2012-12-05 2020-12-18 키에시 파르마슈티시 엣스. 피. 에이. 포스포디에스테라제 억제제로서 1-페닐-2-피리디닐 알킬 알코올의 유도체
JP5846185B2 (ja) 2013-11-21 2016-01-20 大日本印刷株式会社 貫通電極基板及び貫通電極基板を用いた半導体装置
PT109030B (pt) * 2015-12-15 2019-09-25 Hovione Farmaciência, S.A. Preparação de partículas inaláveis de zafirlucaste

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9604752D0 (sv) * 1996-12-20 1996-12-20 Astra Ab Formulation and use
AU726210B2 (en) * 1997-03-13 2000-11-02 Merck Frosst Canada Ltd. Quinoline leukotriene antagonists
SE9704644D0 (sv) * 1997-12-12 1997-12-12 Astra Ab New use

Also Published As

Publication number Publication date
BR0015172A (pt) 2002-06-18
NO20022103L (no) 2002-05-02
MXPA02004334A (es) 2002-11-07
CA2388657A1 (en) 2001-05-10
AU1652601A (en) 2001-05-14
IL149365A0 (en) 2002-11-10
WO2001032166A1 (en) 2001-05-10
WO2001032163A1 (en) 2001-05-10
KR20020050254A (ko) 2002-06-26
AU1321401A (en) 2001-05-14
CN1387431A (zh) 2002-12-25
SE9903995D0 (sv) 1999-11-03
ZA200203178B (en) 2003-07-22
JP2003513037A (ja) 2003-04-08
EP1242065A1 (en) 2002-09-25

Similar Documents

Publication Publication Date Title
NO20006220L (no) &lt;beta&gt;2-adrenergistiske reseptoragonister
DE69800895D1 (de) Interleukin-1 Rezeptor Antagonist beta (il-1rabeta)
NO20004215L (no) Et farmasøytisk preparat som omfatter en angiotensin II type 2-reseptoragonist, og anvendelse derav
NO960081L (no) Östrogen-agonist/antagonister
ATE232200T1 (de) Neuropeptid y5-rezeptorantagonisten
DE69921351D1 (de) 4-aroyl-piperidin-ccr-3 rezeptor antagonisten iii
NO20030098L (no) &lt;Beta&gt;3 adrenergiske agonister
NO20022103L (no) Ny kombinasjon innbefattende en beta 2 (&lt;beta&gt;)2 andrenore- septoragonist og leukotrienreseptorantagonist
NO20010804D0 (no) Muskariniske agonister og antagonister
AU775774C (en) Peroxisome proliferator-activated receptor agonist
ATE416173T1 (de) 1-(3 -heteroarylpropyl- oder -prop -2-enyl) -4- benzylpiperidine als nmda-rezeptor-antagonisten
DE69919171D1 (de) Muskarin-rezeptor antagonisten
MA26890A1 (fr) Metabolites agonistes/ antagonistes d&#39;oestrogenes
NO20004503D0 (no) Vitronectin-reseptor-antagonister
IL138576A0 (en) A novel interleukin-1 receptor antagonist and uses thereof
DK1146874T3 (da) Vitronectinreceptoragonist
NO20013978L (no) Dopamin D1 reseptor agonist forbindelser
IL137428A0 (en) Estrogen agonists and antagonists for multiple indications
SE0003995D0 (sv) Receptoragonister och antagonister
DE69830671D1 (de) Integrin-rezeptor-antagonisten
DK1137413T3 (da) Ikke-peptidantagonister af GLP-1-receptor og anvendelsesfremgangsmåder
GB9822701D0 (en) Intergrin receptor antagonists

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application